Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Nm23/nucleoside diphosphate kinase-A as a potent prognostic marker in invasive pancreatic ductal carcinoma identified by proteomic analysis of laser micro-dissected formalin-fixed paraffin-embedded tissue.

Takadate T, Onogawa T, Fujii K, Motoi F, Mikami S, Fukuda T, Kihara M, Suzuki T, Takemura T, Minowa T, Hanagata N, Kinoshita K, Morikawa T, Shirasaki K, Rikiyama T, Katayose Y, Egawa S, Nishimura T, Unno M.

Clin Proteomics. 2012 Jun 27;9(1):8. doi: 10.1186/1559-0275-9-8.

2.

Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.

Takadate T, Onogawa T, Fukuda T, Motoi F, Suzuki T, Fujii K, Kihara M, Mikami S, Bando Y, Maeda S, Ishida K, Minowa T, Hanagata N, Ohtsuka H, Katayose Y, Egawa S, Nishimura T, Unno M.

Int J Cancer. 2013 Mar 15;132(6):1368-82. doi: 10.1002/ijc.27797. Epub 2012 Sep 14.

3.

c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.

Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S.

Croat Med J. 2003 Aug;44(4):429-34.

4.

Nm23 protein expression in ductal in situ and invasive human breast carcinoma.

Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB.

J Natl Cancer Inst. 1993 May 5;85(9):727-31.

PMID:
8386774
5.

Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis.

Sprung RW Jr, Brock JW, Tanksley JP, Li M, Washington MK, Slebos RJ, Liebler DC.

Mol Cell Proteomics. 2009 Aug;8(8):1988-98. doi: 10.1074/mcp.M800518-MCP200. Epub 2009 May 24.

6.

Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.

Charpin C, Garcia S, Bonnier P, Martini F, Andrac L, Horschowski N, Lavaut MN, Allasia C.

J Pathol. 1998 Apr;184(4):401-7.

PMID:
9664906
7.

Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.

Mandai M, Konishi I, Koshiyama M, Komatsu T, Yamamoto S, Nanbu K, Mori T, Fukumoto M.

Cancer. 1995 May 15;75(10):2523-9.

8.
9.

Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.

Nakopoulou LL, Constandinides CA, Tzonou A, Lazaris AC, Zervas A, Dimopoulos CA.

Histopathology. 1996 May;28(5):429-35.

PMID:
8735718
10.

The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.

Baekelandt M, Holm R, Tropé CG, Nesland JM, Kristensen GB.

Ann Oncol. 1999 Nov;10(11):1335-41.

11.

Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma.

Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Harmsen WS, Ziesmer SC, Roche PC, Podratz KC.

Gynecol Oncol. 1997 Aug;66(2):238-45.

PMID:
9264569
12.

Clinicopathological features and prognostic significance of nucleoside diphosphate kinase/nm23 gene product in human pancreatic exocrine neoplasms.

Nakamori S, Ishikawa O, Ohigashi H, Imaoka S, Sasaki Y, Kameyama M, Kabuto T, Furukawa H, Iwanakga T, Kimura N.

Int J Pancreatol. 1993 Oct;14(2):125-33.

PMID:
8283076
13.

NM23 as a prognostic biomarker in ovarian serous carcinoma.

Youn BS, Kim DS, Kim JW, Kim YT, Kang S, Cho NH.

Mod Pathol. 2008 Jul;21(7):885-92. doi: 10.1038/modpathol.2008.64. Epub 2008 Apr 11.

14.

Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.

Müller W, Schneiders A, Hommel G, Gabbert HE.

Cancer. 1998 Dec 15;83(12):2481-7.

PMID:
9874452
15.

Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.

Soliani P, Ziegler S, Romani A, Corcione L, Campanini N, Dell'Abate P, Del Rio P, Sianesi M.

Oncol Rep. 2004 Jun;11(6):1193-200.

PMID:
15138555
16.

Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.

Goncharuk VN, del-Rosario A, Kren L, Anwar S, Sheehan CE, Carlson JA, Ross JS.

Ann Diagn Pathol. 2004 Feb;8(1):6-16.

PMID:
15129904
17.

Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.

Tsutsumi K, Sato N, Tanabe R, Mizumoto K, Morimatsu K, Kayashima T, Fujita H, Ohuchida K, Ohtsuka T, Takahata S, Nakamura M, Tanaka M.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S491-9. doi: 10.1245/s10434-011-1970-2. Epub 2011 Aug 12.

PMID:
21837532
18.

Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion.

Nakamori S, Ishikawa O, Ohhigashi H, Kameyama M, Furukawa H, Sasaki Y, Inaji H, Higashiyama M, Imaoka S, Iwanaga T, et al.

Clin Exp Metastasis. 1993 Mar;11(2):151-8.

PMID:
8383029
19.

Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.

Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC.

Gynecol Oncol. 1996 Mar;60(3):363-72.

PMID:
8774640
20.
Items per page

Supplemental Content

Write to the Help Desk